Clinical Advances and Challenges in Glaucoma and Glaucoma Surgery
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 29 May 2024 | Viewed by 170
Special Issue Editor
Special Issue Information
Dear Colleagues,
The progress in glaucoma over the last decade has been remarkable. From emerging glaucoma genetic insights into the disease pathology to the development of new optimized minimally invasive glaucoma (MIGs) procedures, we now have numerous opportunities to better understand this disease as well as surgically intervene to effectively lower IOP. Moreover, the new development of and insight into potential neuroprotective compounds such as nicotinamide in clinical studies make us hopeful that we may have a handle and opportunity for neuro preservation and even neuro regeneration of the optic nerve in the future. An understanding of relevant pathologic mechanisms has expanded steadily, especially in terms of the value of home IOP monitoring, as well as new therapies that have never existed. These are being developed and implemented in ongoing clinical trials including an approach for lowering episcleral venous pressure (EVP). For this Special Issue, we welcome authors to submit papers on the clinical advance of MIGs, neuroprotective and optic nerve perfusion innovations, stem cell and regenerative developments, as well as clinical cases, surgical insights and diagnosis and treatment advancements that can help move our field forward.
Dr. Barbara Wirostko
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmology
- glaucoma
- glaucoma surgery
- exfoliation syndrome
- iCare Home IOP monitoring
- clinical trials
- drug and device development
- MIGs procedures
- EVP
- neuroprotection
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: The Role of Stress Reduction and Mindfulness Meditation in Glaucoma Management: A Review
Authors: Ashley Polski
Affiliation: Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, UT, USA
Abstract: Abstract: Glaucoma is a progressive optic neuropathy that is increasing in prevalence worldwide and can lead to devastating vision loss and even blindness if left untreated. Current medical and surgical approaches to glaucoma treatment all aim to lower intraocular pressure (IOP), which is a well-known risk factor for glaucoma development and progression. Although the exact patho-genesis of glaucoma is not yet fully elucidated, multiple recent studies suggest that mental stress and elevated cortisol levels may contribute to IOP elevation and glaucomatous progression. In this review, we discuss the relationship between mental stress and glaucoma, and we highlight the potential role of mindfulness meditation as an adjunctive strategy to reduce IOP in glaucoma patients.
